Navigation Links
Australian study sheds light on kidney repair and disease
Date:9/30/2009

A study by Monash University researchers has shed new light on the microscopic antennas in the kidney that are involved in the organ's repair process.

The work may be a crucial step towards a cure for polycystic kidney disease, a potentially fatal disease that affects more than one in 1000 people.

The study, led by Dr James Deane a researcher at the Centre for Inflammatory Disease at the Monash Medical Centre, showed how kidney repair processes are controlled and helps explain the cause of polycystic kidney disease.

The findings have appeared in the latest edition of world's leading kidney research publication, the Journal of the American Society of Nephrology.

"We have shown for the first time that the hair-like structures on kidney cells, called cilia, change their length in response to injury in human patients, growing up to four times their original length in the later stages of kidney repair," Dr Deane said.

"These hair-like structures are antennas and the increases in their length amplify the signals they send to kidney cells at vital stages of repair. We think this is how they turn off the repair process when it is complete and allow the kidney to start working normally again"

Dr Deane said that if the switching on and off the repair process is not properly controlled, rapidly reproducing cells will distort the tubes of the kidney and prevent them from functioning properly, which is what appears to happen in people that have polycystic kidney disease, a condition which is currently untreatable.

"Our research helps put a logical framework behind what is happening in polycystic kidney disease, as the mutations that cause the disease can damage the hair-like structures of kidneys cells," Dr Deane said.

"We hope that this work will lead to new ways of treating both kidney injury and polycystic kidney disease."

The kidney is made up of about a million tiny living tubes
'/>"/>

Contact: Dr James Deane
james.deane@med.monash.edu.au
61-395-945-528
Monash University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Invasive Australian jellyfish sighted in Gulf of Mexico in summer 2007
2. Australian researchers develop treatment to treat obesity
3. Fertilizer research center an Australian first
4. Oldest Australian crayfish fossils provide missing evolutionary link
5. Australian frog species chooses not to put eggs in 1 basket
6. Crafty Australian crayfish cheat
7. Australian filmmakers are stars of science film awards
8. Energy experts helping Australian households reduce carbon emissions
9. Childhood obesity indicates greater risk of school absenteeism, Penn study reveals
10. A study by the MUHC and McGill University opens a new door to understanding cancer
11. Study begins to reveal clues to the cause and progression of sepsis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... September 23, 2014 A new American Cancer Society ... Assistance Program (SNAP), previously known as the food ... with income eligible non-participants. The authors say the ... at enhancing the dietary quality of SNAP participants. ... individuals and households with the resources to obtain ...
(Date:9/22/2014)... researchers are studying a potential new treatment that reverses ... which scars develop in the lungs and severely hamper ... which is delivered to lung tissue intravenously. In mouse ... fibrosis after several days. , The findings were ... Medicine . , "The mimic, when injected into the ...
(Date:9/22/2014)... genetic sequencing technologies continue to evolve rapidly, becoming part ... establish appropriate policies and regulatory frameworks to address potential ... policy issue of the Journal of Law, Medicine ... experts with the Center for Medical Ethics and Health ... the tools to jumpstart this process. , Experts ...
Breaking Biology News(10 mins):Federal food program puts food on the table, but dietary quality could be improved 2Reversing the effects of pulmonary fibrosis 2Experts provide much-needed policy analysis for clinical integration of next generation sequencing 2Experts provide much-needed policy analysis for clinical integration of next generation sequencing 3
... Director,s T-R01 Award , Speedier Lab Testing With Results ... associate professor of pharmacology at Weill Cornell Medical College, ... NIH Director,s Transformative R01 award from the National Institutes ... innovative protein recognition technologies that may some day speed ...
... Fisher, associate professor in the Fischell Department of Bioengineering, ... Research and Technology Review Day with a tissue engineering ... tissue for implantation. Fisher,s technology was one of ... faculty members and graduate students at the Professor Venture ...
... Researchers have shown how an experimental drug might restore ... by preventing short circuits caused when tiny "potassium channels" ... also might be developed as a treatment for multiple ... a common type of spinal cord trauma, called "compression" ...
Cached Biology News:Weill Cornell science briefs: November 2009 2Weill Cornell science briefs: November 2009 3Weill Cornell science briefs: November 2009 4Weill Cornell science briefs: November 2009 5Bioreactor for bone tissue engineering wins professor venture fair 2Bioreactor for bone tissue engineering wins professor venture fair 3Drug studied as possible treatment for spinal injuries 2Drug studied as possible treatment for spinal injuries 3
(Date:9/23/2014)... 2014 Marktech Optoelectronics has introduced the ... emitters in the 280 nm wavelength range. This series ... range from 280nm to 405nm. These new devices are ... well as curing. Mark Campito, Marktech’s CEO states that ... to manufacturers is that we offer it in one ...
(Date:9/23/2014)... September 23, 2014 New ... Imperial Innovations, Cambridge Innovation Capital and Johnson & ... cancer genomics company focused on harnessing the potential ... cancer testing and treatment, today announced it has ... Imperial Innovations and including Cambridge Innovation Capital and ...
(Date:9/22/2014)... -- Research and Markets ( http://www.researchandmarkets.com/research/94pdq3/global ... "Global Biotechnology Reagents Market 2014-2018" report to ... Biotechnology reagents are chemical compounds or substances ... and examine another substance to provide a test ... prepare, collect, and examine specimens from the human ...
(Date:9/22/2014)... generated a new star-shaped molecule made up of interlocking rings, ... , Known as a ,Star of David, molecule, ... quarter of a century and the team,s findings are published ... of two molecular triangles, entwined about each other three times ... each triangle is 114 atoms in length around the perimeter. ...
Breaking Biology Technology:Marktech Introduces its New Line of Deep UV Emitters 2Inivata Raises £4m to Realise the Potential of ctDNA Analysis to Improve Cancer Treatment Through Simple Blood Tests 2Inivata Raises £4m to Realise the Potential of ctDNA Analysis to Improve Cancer Treatment Through Simple Blood Tests 3Inivata Raises £4m to Realise the Potential of ctDNA Analysis to Improve Cancer Treatment Through Simple Blood Tests 4Global Biotechnology Reagents Market 2014-2018: Key Vendors are Agilent, BD Biosciences, Bio-Rad, F. Hoffmann-La Roche, Sigma-Aldrich and Thermo Fisher 2Global Biotechnology Reagents Market 2014-2018: Key Vendors are Agilent, BD Biosciences, Bio-Rad, F. Hoffmann-La Roche, Sigma-Aldrich and Thermo Fisher 3
... Simbionix,the world,s leading developer of medical simulation systems, ... a global collaboration,agreement. Simbionix will exclusively distribute, market, ... virtual reality hysteroscopy simulator. , ... simulators for minimal,invasive surgery. "This new agreement further ...
... Put in Place to Serve Future Requirements of Stem ... SIAL ) today announced the launch of an ... to its extensive portfolio of industry-leading products developed specifically ... over 1,100 unique and highly-focused products that are expected ...
... All amounts are in U.S. dollarsQUEBEC CITY, March 11 /PRNewswire-FirstCall/ - ... Company"), a global biopharmaceutical company focused on endocrinology and oncology, today ... full year ended December 31, 2008., 2008 Highlights, ... First patients treated with AEZS-108 for a Phase 2 trial in ...
Cached Biology Technology:Simbionix Increases Product Offerings for OB/GYN Physicians 2Sigma-Aldrich Streamlines Access to Advanced Stem Cell Research Portfolio and Opens Stem Cell Biology Community Through New Web Portal 2Sigma-Aldrich Streamlines Access to Advanced Stem Cell Research Portfolio and Opens Stem Cell Biology Community Through New Web Portal 3AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results 2AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results 3AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results 4AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results 5AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results 6AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results 7AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results 8AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results 9AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results 10
Small bottle for hybridization 150 x 35mm...
... Forma stacking shakers have the ... speed stacked 3-high, and the ... sensitive "soft shake" applications. ... and systems, our stackers are ...
CQCS kit for first KR 4i , (first unit)....
Multidrop Micro high speed 1 l bulk reagent dispenser rapidly, precisely and accurately dispenses microvolumes of 1-50 l into 384- and 96-well microplates....
Biology Products: